Drug stocks inch up; Ipsen gains for second day

Drug stocks inch higher in early trading as shares of French drugmaker Ipsen SA climb for the second day on positive clinical data for its diabetes drug candidate taspoglutide.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.